ReNeuron Group

(RENE)
Sector: Pharmaceuticals & Biotechnology
3.38p
-0.00p -2.96
Last updated:

Company News Headlines

Date Time Headline Source
02/09/2024 07:00 Cancellation - ReNeuron Group Plc RNS
30/08/2024 07:00 Corporate update and AIM cancellation RNS
02/08/2024 12:25 Corporate Update RNS
26/06/2024 15:33 Change of Registered Address RNS
05/06/2024 15:36 Creditor’s decision on Administrators' Proposals RNS
17/05/2024 12:45 Publication of Joint Administrators' Proposals RNS
08/05/2024 07:00 Update on Administration Process RNS
17/04/2024 11:30 Directorate Change RNS
20/03/2024 15:43 Appointment of Administrators RNS
20/03/2024 12:30 Intention to Appoint Administrators RNS
01/03/2024 07:00 Block Listing Review & Total Voting Rights RNS
05/02/2024 14:30 Corporate update and suspension of trading on AIM RNS
05/02/2024 14:30 Suspension - ReNeuron Group plc RNS
27/11/2023 08:53 Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™ EQS Group
08/11/2023 07:01 Interim Results for the six months ended 30 Sept RNS
08/11/2023 07:00 ReNeuron presents in vivo data at Cell 2023 RNS
04/09/2023 07:00 R&D Update RNS
01/09/2023 07:00 Block Listing Review & Total Voting Rights RNS
29/08/2023 07:00 Director declaration RNS
22/08/2023 10:34 Result of AGM RNS
24/07/2023 17:20 Notice of AGM RNS
12/07/2023 11:57 Share Purchase by Chief Financial Officer RNS
16/06/2023 17:12 Share Purchase by Senior Independent NED RNS
16/06/2023 14:26 Share Purchase by Executive Chairman RNS
16/06/2023 07:00 Posting of Annual Report & Accounts RNS
05/06/2023 16:30 Holding(s) in Company RNS
25/05/2023 07:00 Unaudited Preliminary Results RNS
18/05/2023 07:00 Notice of Results RNS
17/05/2023 08:56 Holding(s) in Company RNS
27/04/2023 08:18 Holding(s) in Company RNS
06/04/2023 16:17 Share Purchase by Senior Independent NED RNS
03/04/2023 07:00 New Scientific Advisory Board RNS
28/03/2023 14:23 Director/PDMR Shareholding RNS
23/03/2023 07:00 Change of adviser RNS
09/03/2023 16:03 Holding(s) in Company RNS
03/03/2023 09:37 Share Purchase by Chief Financial Officer RNS
01/03/2023 07:01 Block listing application RNS
01/03/2023 07:00 Block Listing Review & Total Voting Rights RNS
24/02/2023 11:20 Director Share Purchases RNS
15/02/2023 07:00 Grant of Options RNS
30/01/2023 16:38 Director/PDMR Shareholding RNS
27/01/2023 11:05 Second Price Monitoring Extn RNS
27/01/2023 11:00 Price Monitoring Extension RNS
24/01/2023 10:55 Share Purchase by Chief Financial Officer RNS
23/01/2023 15:04 Share Purchase by Executive Chairman RNS
19/01/2023 07:00 Company restructuring update RNS
03/01/2023 07:02 Total Voting Rights RNS
03/01/2023 07:00 Directorate Change RNS
12/12/2022 14:31 Holding(s) in Company RNS
02/12/2022 16:40 Second Price Monitoring Extn RNS